Riskpilot← Back to searchSign inGet full accessAlcor Medica AB
ABActiveOrg 5567987283Kremlavägen 6Dental practice care activities · NACE 8623Est. 20105 employees
Revenue 2024
SEK 13,8M
+7% vs 2023
EBITDA margin
28.4%
-15% vs 2023
Equity ratio
86.8%
Financial strength
Net profit 2024
SEK 5,7M
-5% vs 2023
| Revenue | SEK 13,8M | +7% |
| EBITDA | SEK 3,9M | -15% |
| Net profit | SEK 5,7M | -5% |
| Total assets | SEK 44,7M | +12% |
| Equity | SEK 38,8M | +16% |
| Employees | 5 | — |
Legal name
Alcor Medica AB
Org number
5567987283
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
4 januari 2010
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandläkarverksamhet, ambulerande käkkirurgi. Bolaget ska bedriva fastighetsförvaltning och aktiehandel samt därmed förenlig verksamhet.
Address
Kremlavägen 6
Email
peter_ohannessian@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 765 | 10 930 | 11 883 | 12 942 | 13 838 |
| Staff expenses | — | — | −3 165 | −2 864 | −3 298 |
| EBITDA | 4 245 | 5 454 | 3 487 | 4 611 | 3 930 |
| Depreciation & amort. | −191 | −323 | −65 | −350 | — |
| EBIT | 4 054 | 5 131 | 3 422 | 4 261 | 3 930 |
| Net financials | 554 | 366 | 482 | 721 | 2 780 |
| Profit before tax | 4 766 | 4 929 | 3 922 | 7 535 | 6 710 |
| Tax | −939 | −980 | −744 | −1 520 | −973 |
| Net profit | 3 827 | 3 949 | 3 178 | 6 014 | 5 737 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 29 950 | 34 021 | 36 327 | 39 788 | 44 702 |
| Equity | 20 575 | 24 158 | 27 336 | 33 351 | 38 788 |
| Long-term debt | 1 445 | 1 180 | 170 | 0 | 0 |
| Short-term debt | 471 | 655 | 811 | 979 | 455 |
| Total debt | 1 916 | 1 835 | 980 | 979 | 455 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20202024
Equity ratio
86.8%
This company
38.2%
Market median
+127% vs market
20202024
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
41.5%
This company
8.1%
Market median
+412% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PB Chief Executive Officer | Chief Executive Officer | 2021 |
JP Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AA | Audit | 2021 – 2022 |
CR | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alcor Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Berj Ohannessian | Chief Executive Officer | 0 companies |
| Andreas Andrzej Sygut | Audit | 0 companies |
| Jacob Per Gidmark | Chief Auditor | 0 companies |
| Christian Robert Kromnér | Audit | 0 companies |
| Arossiac Vartevar | Deputy Board Member | 0 companies |